WallStreetZenWallStreetZen

NASDAQ: CMND
Clearmind Medicine Inc Stock Ownership - Who owns Clearmind Medicine?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Clearmind Medicine Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CMND insiders and whales buy or sell their stock.

CMND Shareholders

What type of owners hold Clearmind Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Advisorshares Investments LLC0.44%6,632$5.17kInstitution
Royal Bank Of Canada0.00%14$10.92Institution
Jpmorgan Chase Co0.00%5$3.90Institution

1 of 1

CMND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMND0.44%0.00%
NCEL0.00%0.00%
ENVB4.05%45.96%
DRMA0.59%99.41%
VRAX0.53%0.00%
View Top Biotech Stocks

Clearmind Medicine Stock Ownership FAQ

Who owns Clearmind Medicine?

Clearmind Medicine (NASDAQ: CMND) is owned by 0.44% institutional shareholders, 0.00% Clearmind Medicine insiders, and 99.56% retail investors. Advisorshares Investments LLC is the largest individual Clearmind Medicine shareholder, owning 6632.00 shares representing 0.44% of the company. Advisorshares Investments LLC's Clearmind Medicine shares are currently valued at $5.17k.

If you're new to stock investing, here's how to buy Clearmind Medicine stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.